Active, Not Recruiting
Phase II Randomized-registry Embedded Study of Lymphoscintigraphy for Oropharyngeal Neoplasms to Enable Risk-adapted Nodal Guidance for Robotic Surgery and/or Radiotherapy (LONE-RANGR2)
NCT06167291
- Conditions
- Head and Neck Neoplasms, Lymphoscintigraphy, Neoplasms, +8 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States